Anupendra Sharma is the Global VP of Growth & Business Development at Siemens Healthineers within Enterprise Services & Solutions
Previously, he was Senior Investment Partner at Siemens Venture Capital. Anupendra served on the Board of USARAD, Seventh Sense, China Diagnostics (acquired by Actis & Orbimed), Sequenom (NASD: SQNM), BioImagene (acquired by Roche) and Cylex (acquired by Viracor-IBT), and served on the boards of Novira Therapeutics (Acquired by Johnson & Johnson) and Reflectance Medical (acquired by Zoll).
Prior to Siemens Venture Capital, Anupendra worked in M&A at JPMorgan, Salomon Smith Barney and Siemens. Anupendra also worked in strategy consulting for McKinsey, and Pro...
Anupendra Sharma is the Global VP of Growth & Business Development at Siemens Healthineers within Enterprise Services & Solutions
Previously, he was Senior Investment Partner at Siemens Venture Capital. Anupendra served on the Board of USARAD, Seventh Sense, China Diagnostics (acquired by Actis & Orbimed), Sequenom (NASD: SQNM), BioImagene (acquired by Roche) and Cylex (acquired by Viracor-IBT), and served on the boards of Novira Therapeutics (Acquired by Johnson & Johnson) and Reflectance Medical (acquired by Zoll).
Prior to Siemens Venture Capital, Anupendra worked in M&A at JPMorgan, Salomon Smith Barney and Siemens. Anupendra also worked in strategy consulting for McKinsey, and Pro...
